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Abstract Pulmonary arterial (PA) flow is abnormal after
the Fontan operation and is marked by a lack of pulsatility.
We assessed the effects of this abnormal flow on the size
and function of the PA’s in Fontan patients in long-term
serial follow-up. Twenty-three Fontan patients with serial
follow-up were included. Median age was 11.1 (9.5–16.0)
years at baseline and 15.5 (12.5–22.7) years at follow-up.
Median follow-up duration was 4.4 (4.0–5.8) years. Flow
and size of the left pulmonary artery were determined using
phase-contrast MRI. From this wall shear stress (WSS),
distensibility and pulsatility were determined. A group of
healthy peers was included for reference. Flow and pul-
satility were significantly lower in patients than in controls
(p\ 0.001). Mean area was comparable in patients and
controls, but distensibility was significantly higher in
controls (p\ 0.001). Mean and peak WSS were signifi-
cantly lower in Fontan patients (p\ 0.001). Between
baseline and follow-up, there was a significant increase in
normalized flow (15.1 (14.3–19.1) to 18.7 (14.0–22.6) ml/
s/m2, p = 0.023). Area, pulsatility, distensibility and WSS
did not change, but there was a trend toward a lower mean
WSS (p = 0.068). Multivariable regression analysis
showed that flow, area and age were important predictors
for WSS. WSS in Fontan patients is decreased compared to
healthy controls and tends to decrease further with age.
Pulsatility and distensibility are significantly lower com-
pared to healthy controls. Pulmonary artery size, however,
is not significantly different from healthy controls and
long-term growth after Fontan operation is proportionate to
body size.
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Introduction
The Fontan circulation, used as a final palliative approach
for univentricular heart defects, is marked by a direct
connection of the systemic venous return to the pulmonary
arteries (PA) [17]. This leads to passive pulmonary blood
flow that is no longer driven by a subpulmonary ventricle.
As a result, these children have an abnormal flow pattern in
their PAs early on in life, characterized by a nearly com-
plete loss of pulsatility [13, 26].
It is hypothesized that this abnormal flow and pulsatility
could influence PA growth and function on the long term.
Since the Fontan circulation is dependent on a low
transpulmonary pressure gradient, it is important to moni-
tor the development of these vessels. Not only is
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longitudinal data on PA size and function in the Fontan
circulation scarce, but studies investigating PA size in
Fontan patients have also shown conflicting results [24, 26,
32].
Wall shear stress (WSS) is important in the development
of vasculature [7]. Reduced levels of WSS have been
related to PA endothelial dysfunction [9]. There is an
inverse relation between vessel diameter and WSS [6]. A
previous study from our center has shown that WSS is
reduced in Fontan patients during rest, and also during
exercise [26].
To date, only few studies have investigated PA growth
using MRI long term after the Fontan operation. No studies
have measured the course of WSS over time in Fontan
patients.
The objective of this study was to assess PA growth,
function and WSS over time in Fontan patients using MRI.
Methods
Patients
All patients participated in an ongoing cross-sectional
multicenter study in the Netherlands. Patients who under-
went Fontan operation at young age, either according to an
atriopulmonary connection or a total cavopulmonary con-
nection (TCPC), were included. Patients with mental
retardation and contraindications for cardiac magnetic
resonance imaging (CMR) were excluded. Informed con-
sent was obtained from all patients and/or their parents.
The study was approved by the institutional review boards
of the participating centers. The study was conducted in
accordance with the Helsinki Declaration. Medical records
were reviewed for anatomical and operative details.
MRI Imaging
In an earlier study by our group, we showed that accurate
flow measurement in the RPA was not feasible in every
patient because of the short distance between the connec-
tion of the superior caval vein and the first branching point
of the RPA. Comparison of LPA and RPA flow in the
aforementioned study did not show any significant differ-
ences in flow parameters between both PA’s [26]. There-
fore, we analyzed left pulmonary artery (LPA) only.
All MRI scans were performed on a 1.5T whole-body
MRI system in the participating centers (General Electric
Signa, Philips Achieva and Siemens Avanto). The LPA
was localized on a transverse steady-state free precession
(SSFP) image set. On this transverse image, another
localizer was planned longitudinally along the LPA. Using
both these imaging planes, a flow measurement plane was
planned perpendicular to the flow direction. Specific care
was taken to match the imaging planes between both visits.
In-plane resolution was between 1.1 and 1.6 mm,
depending on patient size. Slice thickness was 6 mm.
Phase-contrast measurements were obtained using unidi-
rectional velocity encoding (VENC) of 60 cm/s. In case of
aliasing, this VENC was stepwise increased with incre-
ments of 20 cm/s until aliasing disappeared. Flow was
measured over 24 phases per cardiac cycle. To incorporate
the effect of breathing, which is essential in the pulmonary
circulation of Fontan patients, phase-contrast flow mea-
surements were made without breath-holds and with three
signal averages.
LPA contours were drawn on all phases using Flow
Analysis software (Medis Medical Imaging Systems) to
determine mean, maximal and minimal areas and mean,
maximal and minimal flows.
Distensibility, which is the maximum change in cross-
sectional area during the cardiac cycle, and pulsatility,
which is the flow change during the cardiac cycle, were
calculated according to the following formulas:
distensibility ¼ maximal areaminimal areað Þ
maximal area
pulsatility ¼ maximal flowminimal flowð Þ
mean flow
WSS Calculation
WSS was calculated by multiplying dynamic viscosity by
wall shear rate (WSR). The latter is the radial gradient of
the velocities at the wall. The formula of WSS is shown
below:
s ¼ ldu
dr




r¼0
where l is the dynamic viscosity of blood, u is the blood
velocity and r is the radius. The blood viscosity was set as
3.2 P. WSR was calculated according to van Duivenvoor-
den et al. [8]. In short, blood flow velocities were calcu-
lated within the LPA contours using the MRI phase-
contrast images. Velocities within a distance of C0.5 pixels
to the outer lumen border were excluded since those pixels
were partially located outside of the lumen. The cross
section was divided into four segments with 10 of overlap.
In each segment, the velocities were projected onto one
plane. Assuming blood velocity to be zero at the lumen
wall, the projected velocities within 3 pixel distance
inwards were fit with a second order curve and wall shear
rate (WSR) per segment was calculated for each time point.
WSS was calculated by multiplying WSR with the blood
viscosity (3.2 P). We averaged the WSS values of four
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segments to obtain mean cross-sectional WSS. The anal-
ysis was performed on cardiac cycle-averaged WSS only
[8].
Healthy Controls
In healthy controls RPA was chosen for the flow and WSS
analysis over the LPA since the first branching point of the
LPA was closer to the bifurcation than the branching point
of the RPA leading to disturbed flow signals in the LPA
images. Images in these controls were acquired as part of
another study protocol and were only acquired at one point
in time. In this study, VENC was 150 cm/s, and images
were taken during breath-hold at expiration [26].
Statistical Analysis
Statistical analysis was performed using SPSS 21.0. Data
were tested for normal distribution and expressed as
mean ± standard deviation or median (interquartile range)
as appropriate. Results were corrected for body surface
area (BSA). Comparisons between Fontan patients and
healthy controls were made using independent T test or
Mann–Whitney U test as appropriate. To compare mea-
surements between baseline and follow-up, paired samples
T test or Wilcoxon singed-rank test were used. p values
B0.05 were considered statistically significant. In order to
identify predictors for WSS, linear regression analysis was
performed. The relation between (non-log-transformed)
age and WSS was nonlinear. In order to be able to perform
multivariable regression analysis, we log-transformed age
to obtain linearity. A p value B0.05 was required for a
variable to be retained in the final model.
Results
Twenty-eight patients underwent two MRI studies each
with flow measurements of the LPA. In four patients,
scanning planes did not properly match between both vis-
its. These patients were therefore excluded. Another patient
underwent a conversion from APC to extracardiac conduit
(ECC) TCPC with concomitant PA surgery between both
visits and was therefore excluded. There were no inter-
ventions during follow-up in the other patients. There were
no patients with patent fenestrations at the time of both
visits. There were no patients with large caliber changes or
PA stenosis at the time of both visits.
The remaining 23 patients were included in the current
analysis. Their characteristics are shown in Table 1.
Median age at first visit was 8.1 (6.9–9.4) years and 12.3
(10.4–16.1) at the second visit. Median follow-up duration
between both visits was 4.4 (4.0–5.8) years. All patients
underwent the Fontan operation before the age of 7 years.
An atriopulmonary connection was performed in two
patients, all other patients had a TCPC (ILT n = 16, ECC
n = 5). In most TCPC patients (17 out of 21), the TCPC
was performed in a staged manner, preceded by a bidi-
rectional Glenn shunt.
In eight patients, the initial procedure consisted of the
creation of a BT shunt (Norwoord stage I excluded), and
these patients were therefore considered to have an
impaired pulmonary blood flow pre-surgery.
Comparison with Controls
Table 2 shows the results of MRI measurements and WSS
calculations for controls as well as for both visits for the
patients. Mean flow, maximal flow and pulsatility were all
significantly lower in patients than in controls, for both
visits. There was a large difference in pulsatility within the
patient group, between TCPC patients (range 0.22–2.88)
and those with an APC (range 4.21–9.69). Mean and
maximum areas were not significantly different between
patients and controls, but distensibility was significantly
lower in patients for both visits. Mean and maximal WSS
were both significantly lower in patients, with the most
distinct difference between patients and controls for max-
imal WSS.
Comparison Between Baseline and Follow-Up
The comparison between baseline and follow-up within the
patients is also shown in Table 2. Mean and maximal flows
(corrected for BSA) were significantly higher at follow-up.
While absolute (not corrected for BSA) mean and maximal
area increased significantly (mean area 156 ± 54 vs.
173 ± 57 mm2, p = 0.005; max area 186 ± 66 vs.
203 ± 65 mm2, p = 0.010), BSA-corrected mean and
maximal areas did not change (Fig. 1). Distensibility and
pulsatility were comparable between both visits. There was
a trend toward lower mean and maximal WSS at the second
visit, but the range of values was wide. Figure 2 illustrates
the change of mean WSS with age. WSS is highest at a
younger age, declines with increasing age and levels off at
the later teen age. There was a linear relation between log-
transformed age (logAge) and BSA-corrected mean WSS
(b = -0.606, p\ 0.001, R2 = 0.339).
Predictors for WSS
Results of multivariable regression analysis for WSS ((N/
m2)/m2) are shown in Table 3. LogAge, mean area, mean
flow, pulsatility and distensibility were entered in the
model. Since pulsatility was much higher in APC patients,
these were excluded from the multivariable analysis.
Pediatr Cardiol (2016) 37:637–645 639
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Table 1 Patient characteristics
Baseline parameters Patients baseline (n = 23) Patients follow-up (n = 23) Controls (n = 16)
Male/female (n) 16/7 8/8
Age at study (years) 11.1 (9.5–16.0) 15.5 (12.5–22.7) 13.5 (12.1–15.5)
BSA (m2) 1.15 (1.02–1.78) 1.53 (1.28–1.77) 1.56 (1.36–1.69)
Age at Fontan completion (years) 3.3 ± 1.6
Follow-up since Fontan completion 8.1 (6.9–9.4) 12.3 (10.4–16.1)
Cardiac diagnosis (n)
Tricuspid atresia 7
Hypoplastic left heart syndrome 3
Double inlet left ventricle 5
Double outlet right ventricle 3
Other 5
Dominant ventricle (n)
Left 17
Right 6
Impaired pulmonary blood flow pre-surgery 8
Fontan type
TCPC; ILT 16
TCPC; ECC 5
APC 2
Pre Fontan procedures
BT shunt 8
PA banding 9
Norwood 3
Rashkind 2
Bidirectional Glenn 17
BSA body surface area, TCPC total cavopulmonary connection, APC atriopulmonary connection, ILT intra-atrial lateral tunnel, ECC extracardiac
conduit, BT shunt Blalock-Taussig shunt, PA banding pulmonary artery banding
Table 2 Comparison of flow
and WSS variables
Controls Patients p value
Baseline Follow-up
HR (/min) 73 ± 11 76 ± 18 70 ± 16 0.112
Mean flow (ml/s/m2) 33.5 (27.2–37.5) 15.1 (14.3–19.1)* 18.7 (14.0–22.6)* 0.023#
Max flow (ml/s/m2) 101.8 (95.4–125.7) 23.8 (20.3–33.2)* 28.5 (24.4–37.5)* 0.031#
Pulsatility 3.32 (3.09–3.63) 1.05 (0.73–2.21)* 1.19 (0.59–1.79)* 0.605
Mean area (mm2/m2) 109 ± 22 113 ± 36 113 ± 38 0.966
Max area (mm2/m2) 143 ± 32 125 ± 40 123 ± 40 0.730
Distensibility 0.47 ± 0.13 0.17 ± 0.05* 0.15 ± 0.04* 0.167
Mean WSS ((N/m2)/m2) 0.50 (0.42–0.57) 0.36 (0.26–0.40)* 0.31 (0.26–0.40)* 0.068
Max WSS ((N/m2)/m2) 1.45 (1.24–1.59) 0.54 (0.47–0.62)* 0.47 (0.37–0.62)* 0.078
p values indicate differences between baseline and follow-up
* Significant difference between patients and controls
# Significant difference between baseline and follow-up, HR: heart rate, WSS: wall shear stress
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Fig. 1 a Absolute mean area
(mm2) per patient versus age
(years). b Mean area corrected
for BSA (mm2/m2) per patient
versus age (years)
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Pulsatility and distensibility did not show a significant
relation with WSS. In the final model, log age, mean flow
and mean area explain 85 % of the variability in WSS.
Discussion
This study shows that PA size in growing Fontan patients is
comparable to healthy controls and increases with age,
appropriate to body size. Flow in the LPA increased sig-
nificantly between both visits, but was still lower than in
healthy controls. Pulsatility and distensibility were
impaired and did not change over time, despite increase in
flow. WSS was not significantly different between baseline
and follow-up. Multivariable regression analysis revealed
that age, mean flow and mean area are important predictors
for WSS that explain most of the variability.
PA Size
Several studies have assessed the range of branch PA size
in healthy children and the relation with age and/or body
size. Using contrast-enhanced MRI, Knobel and colleagues
have shown that there is a linear relation between BSA and
PA size [20]. Using echocardiography, an older study
showed a similar trend in younger children [28]. Our
results indicate that LPA growth is proportionate to BSA in
Fontan patients.
Only a few studies have investigated pulmonary artery
size in Fontan patients using MRI. LPA size in our patients
was comparable to that found in a previous smaller sample
from our institutions [26]. Bellsham-Revell and colleagues
investigated growth of the LPA between the hemi-Fontan
stage and the TCPC in patients with hypoplastic left heart
syndrome (HLHS) [4]. The (BSA-corrected) size of the
LPA pre-TCPC in their study was comparable to the values
that we have presented. In the study by Bellsham-Revell, it
was found that, while there was an increase in area of the
proximal LPA between stages, there was a relative
decrease in size of the narrowest part of the LPA. The
authors stated that the staged Fontan approach might be a
risk factor itself for the narrowing of the LPA in these
HLHS patients [4]. Earlier studies have shown that LPA
stenosis is a well-known problem, particularly in HLHS
patients [3]. In our population, there were only a few
Fig. 2 Mean WSS ((N/m2)/m2)
per patient versus age (years)
Table 3 Multivariable regression model (for TCPC patients only) for
mean WSS ((N/m2)/m2)
Variable b p value R2
Constant 1.227 \0.001 0.845
Log age (log years) -0.727 \0.001
Mean flow (ml/s/m2) 0.022 \0.001
Mean area (mm2/m2) -0.004 \0.001
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patients with HLHS. LPA areas in these patients (range
50–102 mm2/m2) were among the lowest sizes measured in
our study. The previous studies and our results emphasize
the need for close surveillance in this specific group.
Other studies have used X-ray catheter-assisted
angiography to measure PA size, usually using the Nakata
index [16, 22]. Although this makes comparison chal-
lenging, a previous study in patients with congenital heart
disease has shown excellent agreement between angiogra-
phy and MRI measurements of the great arteries, including
branch pulmonary arteries [34].
In a recent study, Schmitt et al. [29] found a decreased
Nakata index of 150 mm2/m2 in 10 Fontan patients. Con-
verting this number into a single PA branch area as we
have measured would result in a PA size of 75 mm2/m2,
which is lower than we found. This difference might be
explained by the fact that patients in the study by Schmitt
were older and all of their patients had an unfenestrated
extracardiac conduit Fontan.
Few studies have assessed PA size longitudinally after
Fontan completion. One study showed that Nakata index
decreased after Fontan completion, but did not affect
functional outcome [1]. Another retrospective study also
showed that PA growth failed to match the increase in BSA
in Fontan patients [32]. A recent study by Restrepo and
colleagues, using MRI-derived 3D reconstructions of 25
TCPC patients, showed a similar trend. While there was an
increase in absolute vessel diameters, normalized diameters
decreased significantly with age [24].
In a larger study, the same group confirmed their find-
ings of PA size change during serial follow-up [25]. Fur-
thermore, mean flow rates remained unchanged. Using
their extensive experience in this field, the authors showed
that indexed power loss in the Fontan pathway increased
significantly in the cohort, particularly in patients in whom
the minimum normalized left pulmonary artery decreased
[25].
The finding on PA size in the recent Restrepo paper is in
contrast to our measurements [25]. Possible explanations
include different methods for quantification of PA size. In
our study, we have used 2D MRI measurement performed
in a single plane, while calculations performed by Restrepo
et al. were based on a 3D reconstruction of the entire
Fontan pathway. Another possible explanation is the rela-
tively high percentage of patients with HLHS in their
cohort.
PA Function
Interestingly, there was a significant increase in flow nor-
malized to BSA in our patients between baseline and fol-
low-up. This is in contrast to a recent MRI study among 48
TCPC patients with follow-up duration comparable to our
study, showing an increase in absolute flow over time, but
no changes in flow corrected for BSA19. In the afore-
mentioned study, it was shown that indexed power loss
inside the Fontan pathway increases, despite BSA-cor-
rected flow remaining constant [25]. It remains unclear
whether and how adjustment of the pulmonary circulation
to the Fontan circulation occurs. WSS may be a crucial
factor in that process. WSS is known to be lower in Fontan
patients as compared to healthy controls. This is clear from
the mean WSS, but even more so for the maximal WSS
during the cardiac cycle. This is in accordance with an
earlier study [26]. Impairment of WSS in Fontan patients
most likely results from a combination of reduced pul-
monary flow and nearly absent pulsatility [26].
Although not significant, there was a trend toward a
further decrease of WSS with longer follow-up. Plotting
WSS against age showed a strong decrease of WSS at early
teenage age with a stabilization after the age of 15 years. In
multivariable regression analysis, (the logarithm of) age
was an important predictor of WSS, independent from both
body size and PA area.
Loss of pulsatility of blood flow and therefore lower
mean and maximal WSS values have been associated with
endothelial dysfunction of the PA’s [19, 21].
In a study including 10 young patients reduced pul-
satility after bidirectional Glenn correlated to impaired
endothelial relaxation [21]. Another study has demon-
strated abnormal response of the PA’s to exogenous nitrous
oxide (NO) in Fontan patients [18]. Supplemental NO led
to a fall in PVR, suggesting an elevated basal PVR, pos-
sibly related to endothelial dysfunction [18].
A further decrease of the WSS with age could also result
in deterioration of endothelial function, mediated by
endothelin, a potent vasoconstrictor. A study comparing
endothelin receptor expression in failed and non-failed
Fontan patients has shown an overexpression of these
receptors in the failed Fontan group [15].
WSS is also decreased in patients with pulmonary
arterial hypertension (PAH). In contrast to Fontan patients,
PAH patients have dilated pulmonary arteries, due to a
longstanding elevated mean PA pressure [33]. Studies have
shown a negative correlation between vessel size and WSS.
It has been hypothesized that the decreased WSS in PAH
patients leads to an increased arterial stiffness and reduced
distensibility of the PA’s [31, 33].
More direct evidence that the reduced WSS not only
influences the function of the PA’s but also has effect on
the structure of the vessel wall comes from a case report of
a 35-year-old Fontan patient (APC). Immunohistological
analysis revealed serious changes in the composition of the
(main) pulmonary artery wall [2]. There was a profound
reduction of muscular component and fragmentation of
elastic fibers, which might influence distensibility and the
Pediatr Cardiol (2016) 37:637–645 643
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vasodilatory ability. It is likely that this is also true for
younger Fontan patients, operated upon according to cur-
rent techniques, but this should be further investigated.
Clinical Implications
It has been demonstrated that exercise capacity is reduced
in Fontan patients and that it reduces further with age [5].
In the current study, we have shown that WSS also
decreases with age in Fontan patients. The decrease in
WSS might influence endothelial function in the PA’s. In
healthy subjects, there is an increase of distensibility during
exercise with an increase in the release of NO [12]. This
induces vasodilatation and enhances pulmonary blood flow
by a decrease in pulmonary vascular resistance. In Fontan
patients, there often is an increase in pulmonary vascular
resistance during exercise, indicating that this mechanism
is impaired. This contributes to impaired ventricular filling
[10]. A previous study from our institution showed that
Fontan patients are not able to increase stroke volume
during exercise [27]. Other studies have shown similar
results [35]. The abnormal function of the PA’s thus has
direct consequences for exercise function of the patients,
and may contribute to decline of exercise capacity.
Considering these observations, it is of utmost impor-
tance to be able to influence pulmonary vascular resistance
in the Fontan circulation. Several studies using bosentan,
an endothelin receptor antagonist, have not shown signifi-
cant improvement [23, 30]. Another study using sildenafil,
a phosphodiesterase-5 inhibitor, to assess the influence
during exercise in Fontan patients, showed an increase in
stroke volume and cardiac index and a decrease in PVR
during exercise [35]. Exercise capacity improved after
sildenafil administration, but mainly in those patients with
a poor baseline exercise capacity. This indicates that the
reduced endothelial function could be attenuated to affect
exercise capacity. In another study, sildenafil was admin-
istered for a period of 6 weeks, but failed to show a sig-
nificant improvement in exercise capacity [11]. It has been
speculated that this result was caused by the fact that rel-
atively fit Fontan patients were included [14]. Further
studies are necessary to identify those patients that benefit
the most from this potential therapy or to uncover other
potential targets and means for possible therapeutical
intervention.
Limitations
Sample size was relatively small and the Fontan population
is heterogeneous with respect to different cardiac diag-
noses. This may be one of the reasons for differences
between the outcome of this and other recent studies [25].
The subgroups were too small for group-to-group
comparison.
This study assumes laminary flow in the PA’s for the
calculation ofWSS. Although care was taken not to measure
flow too close to the caval connection point, flow distur-
bances may have been present, depending on the individual
anatomy and intravascular flow pattern in patients.
Since measurements were performed in one of the
branch pulmonary arteries, this study does not provide
direct knowledge on the smaller pulmonary vasculature
further downstream.
Conclusions
WSS in Fontan patients is decreased as compared to
healthy controls and decreases further with age. Pulsatility
and distensibility are also significantly lower. Pulmonary
artery size, however, is not significantly different from
healthy controls and growth after Fontan operation remains
proportionate to body size.
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